Association Between Sarcopenia Risk, Disease Severity, and Functional Mobility in Parkinson's Disease: A Cross-Sectional Study

Read full text Summarise with VIRAT
Authors: Hatice Kübra Aşık, Mert Zure, Dilek Ün Oğuzhanasiltürk, Zeynep Karakuzu Güngör
Cited by: 0
References: 23

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Aim: Sarcopenia and Parkinson's disease (PD) share pathophysiological mechanisms that may synergistically accelerate functional decline. This study aimed to investigate the relationship between sarcopenia risk and functional mobility in patients with PD and to compare the clinical and demographic characteristics of patients with low and high sarcopenia risk. Methods: This cross-sectional study enrolled 29 patients with idiopathic PD between October and December 2025. Sarcopenia risk was assessed using the SARC-F questionnaire (cut-off ≥4) and functional mobility using the Timed Up and Go (TUG) test. Disease severity was staged using the Hoehn-Yahr (H-Y) scale. Spearman rank correlation, the Mann-Whitney U test, and independent t-tests were applied; normality was evaluated using the Kolmogorov-Smirnov test. Results: Of 29 participants (mean age 70.59±12.61 years), 65.5% were classified as high sarcopenia risk. The high-risk group was significantly older (75.42 vs. 63.00 years; p=0.008) and had more advanced H-Y staging (2.37 vs. 1.50; p=0.005). Timed Up and Go time was significantly longer in the high-risk group (27.58 vs. 18.30 seconds; p=0.018). SARC-F score correlated strongly with TUG time (r=0.709, p

Fields of Study & Subjects

Nutrition and Health in Aging Balance Gait and Falls Prevention Parkinson's Disease Mechanisms and Treatments

Publication details

Journal / source
Medical Bulletin of Haseki
Volume
64
Issue
2
Pages
147–154
Publication date
27 March 2026
Language
EN